The International Lyme and Associated Diseases Society (ILADS), regards Lyme disease as often difficult to diagnose and treat, resulting in persistent infection in many patients. ILADS recommends individualized treatment based on the severity of symptoms, the presence of tick-borne co-infections and patient response to treatment.
At The MedInstitute we target the complex underlying causes for a more effective treatment. We also employ a variety of protocols to directly treat bacterial, viral, and other pathogenic overgrowth.
We utilize the immune stimulating and antimicrobial activity of complex non-toxic protocols developed in Russian and European universities in addition to Dr. Nikolenko ground-breaking Ozone treatments. Dr Nikolenko research has supported the antimicrobial and immune-stimulating pathways along with demonstrating powerful stem cell activation effects of ozone therapy.